Stockscreener 앱 받기
48.41
0.62%
0.30
시간 외 거래:
48.19
-0.22
-0.45%
전일 마감가:
$48.11
열려 있는:
$48.83
하루 거래량:
23.97M
Relative Volume:
0.66
시가총액:
$10.54B
수익:
$1.78B
순이익/손실:
$164.40M
주가수익비율:
70.16
EPS:
0.69
순현금흐름:
$236.51M
1주 성능:
+14.31%
1개월 성능:
-12.81%
6개월 성능:
+18.39%
1년 성능:
+235.48%
1일 변동 폭
$46.86
$49.16
1주일 범위
$40.78
$49.16
52주 변동 폭
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
명칭
Hims Hers Health Inc
전화
415-851-0195
주소
2269 CHESTNUT ST, SAN FRANCISCO
HIMS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
48.41 | 10.87B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
160.02 | 372.88B | 84.28B | 16.07B | 14.05B | 6.51 |
|
UL
Unilever Plc Adr
|
64.31 | 159.40B | 64.99B | 6.71B | 6.53B | 2.4495 |
|
CL
Colgate Palmolive Co
|
85.13 | 67.62B | 20.00B | 3.05B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
129.89 | 42.86B | 18.88B | 2.38B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
18.62 | 39.42B | 15.14B | 1.42B | 1.63B | 0.74 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-23 | 다운그레이드 | Needham | Buy → Hold |
| 2025-06-04 | 재확인 | Needham | Buy |
| 2025-04-29 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-01-07 | 개시 | BTIG Research | Buy |
| 2024-12-17 | 개시 | Morgan Stanley | Overweight |
| 2024-11-14 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2024-08-22 | 개시 | Needham | Buy |
| 2024-08-09 | 다운그레이드 | Imperial Capital | Outperform → In-line |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-04-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-04-10 | 개시 | Canaccord Genuity | Buy |
| 2024-02-28 | 업그레이드 | Imperial Capital | In-line → Outperform |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2023-12-07 | 개시 | Imperial Capital | In-line |
| 2023-07-28 | 개시 | TD Cowen | Outperform |
| 2023-04-11 | 개시 | Robert W. Baird | Neutral |
| 2023-02-09 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-11-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-08 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-07-15 | 개시 | SVB Leerink | Underperform |
| 2022-04-14 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-10 | 개시 | Deutsche Bank | Hold |
| 2021-12-02 | 개시 | Jefferies | Hold |
| 2021-11-11 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | 개시 | BofA Securities | Neutral |
| 2021-05-20 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | 개시 | Truist | Hold |
| 2021-03-09 | 개시 | Credit Suisse | Neutral |
| 2021-03-02 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-02-17 | 개시 | Citigroup | Neutral |
| 2021-02-12 | 개시 | Piper Sandler | Neutral |
| 2021-02-08 | 개시 | Tigress Financial | Buy |
모두보기
Hims Hers Health Inc 주식(HIMS)의 최신 뉴스
Hers Health Inc. is moving todayNew Guidance & Accurate Buy Signal Notifications - Newser
Hims & Hers Health signs 15-year lease for Ohio facility with $5.98 million annual rent - Investing.com Canada
Hims & Hers Health: Pioneering the Future of Digital Healthcare Amid Secular Megatrends - AInvest
Hims & Hers Health: At The Intersection Of Secular Megatrends (NYSE:HIMS) - Seeking Alpha
Hims & Hers Health Expands with New Ohio Facility - TipRanks
Hers Health Inc. in sector analysisInsider Selling & Weekly Top Gainers Trade List - Newser
Hers Health Inc. stock trendline breakdown2025 Trading Recap & Low Risk High Reward Ideas - Newser
Hims & Hers (HIMS) Steals Spotlight as Court Junks Eli Lilly Lawsuit vs 4 Telehealth Firms - Insider Monkey
Hims & Hers Health: A Disruptive Force in Personalized Digital Healthcare and Its Implications for Long-Term Growth - AInvest
Exclusive: Remedy Meds to acquire Thirty Madison - Axios
Why Hims & Hers Health (HIMS) Stock Is Up Today - TradingView
Sustainable weight loss with Hims & Hers - fox10tv.com
Experts discuss the impact of limited insurance coverage on obesity treatment access - KOKH
BofA Securities maintains Underperform rating on Hims and Hers stock By Investing.com - Investing.com Australia
BofA Securities maintains Underperform rating on Hims and Hers stock - Investing.com
4 Top Stocks to Buy in September - The Motley Fool
HIMS Stock Climbs 7% after Eli Lilly’s Knockoff Case Falls Flat - TipRanks
Navigating the Storm: Hims & Hers' Legal Resilience in the Telehealth and Compounded Drug Sector - AInvest
Eli Lillys 036 Gains Overshadowed by 3075 Volume Drop as Court Dismisses Lawsuit Stock Ranks 33rd in Market Activity Amid Hims Surge - AInvest
Strategic Capital Moves in Disruptive Consumer & Mobility Sectors: Lyft, Hims & Hers, and Constellation Brands - AInvest
Noteworthy Wednesday Option Activity: HIMS, UNH, SMMT - Nasdaq
Lyft convertible notes, Hims & Hers surges, Constellation Brands - Yahoo Finance
Hims & Hers Health Stock (HIMS) Opinions on Telehealth Innovation and Recent Setbacks - Quiver Quantitative
Hims & Hers gains after court rejects Eli Lilly’s case against Willow - Yahoo Finance
Hims & Hers Health Set to Meet Revenue Projections Amid Growing Confidence - StocksToTrade
Hims & Hers Sees Revenue Growth Amid Deutsche Bank’s Optimistic Outlook - timothysykes.com
Hers Health Inc.Weekly Market Report & Community Consensus Picks - Newser
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock - Yahoo Finance
HIMS' Personalized Wellness Platform Expands Preventive Care Access - sharewise.com
Hers Health Inc. holdersEarnings Overview Report & Daily Stock Trend Reports - Newser
Hers Health Inc. reversing from oversold territoryLayoff News & Accurate Buy Signal Notifications - Newser
Hims & Hers Health: Still Undervalued (NYSE:HIMS) - Seeking Alpha
Hers Health Inc. stock trend forecastRisk Management & Reliable Volume Spike Trade Alerts - Newser
Hers Health Inc. bounce back from current support2025 Price Targets & AI Enhanced Trading Signals - Newser
Insider Moves: Datadog, Hims & Hers, Opendoor, Texas Instruments, Vertiv - TipRanks
Hers Health Inc.’s reversalGap Down & Stock Timing and Entry Methods - Newser
Hims & Hers: The Dominant Health Platform Of The Future (NYSE:HIMS) - Seeking Alpha
Real time social sentiment graph for HIMSNew Guidance & Safe Entry Trade Reports - Newser
Hers Health Inc. stock entering bullish territoryTrade Exit Report & Growth Focused Entry Reports - Newser
Hims & Hers Climbs to 102nd in Market Activity With $790M Volume as Insider Sales and Mixed Earnings Spark Doubts - AInvest
Hims & Hers Health Insider Selling: Signal of Distrust or Strategic Rebalancing? - AInvest
Hers Health Inc. in the next 30 daysPortfolio Growth Summary & Weekly Top Gainers Alerts - Newser
HIMS vs. AMWL: Which Stock Has the Stronger Global Growth Strategy? - The Globe and Mail
Hims & Hers Health Stock Plunges 2.95% as Trading Volume Falls 32% to $890M and Drops to 67th in Activity - AInvest
Hims & Hers’ growth prospects clouded by Novo dispute and regulatory scrutiny - S&P Global
HIMS & HERS ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Hims Hers Health Inc (HIMS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.19%
9.35%
자본화:
|
볼륨(24시간):